ORIGINAL ARTICLE HIGHLIGHTS FROM THIS ISSUE

Size: px
Start display at page:

Download "ORIGINAL ARTICLE HIGHLIGHTS FROM THIS ISSUE"

Transcription

1 ORIGINAL ARTICLE HIGHLIGHTS FROM THIS ISSUE The Urticaria Activity Score Validity, Reliability, and Responsiveness Hawro et al 1185 What is already known about this topic? The urticaria activity score (UAS) is an established instrument to measure the activity of chronic spontaneous urticaria. Two versions of this tool exist. For one of them, critical clinimetric data are still missing. What does this article add to our knowledge? We show that both UAS tools have good clinimetric properties. We define the minimal important difference and the smallest detectable change for both instruments. How does this study impact current management guidelines? The guideline-recommended version of the UAS with once-daily documentation of symptoms is valid, reliable, and sensitive to change. Validity, reliability and responsiveness of the UAS version that requires twice-daily documentation are confirmed. Predicting Chronic Spontaneous Urticaria Symptom Return After Omalizumab Treatment Discontinuation: Exploratory Analysis Ferrer et al 1191 What is already known about this topic? Omalizumab treatment can control symptoms in a high percentage of patients with chronic spontaneous urticaria (CSU), but symptoms can return, either fast or slow, after stopping treatment. What does this article add to our knowledge? The results of this study suggest that it is possible to selectively identify patients with CSU who are at risk of rapid symptom return after omalizumab treatment discontinuation. How does this study impact current management guidelines? Based on our findings, a simple digital tool could be developed and used to estimate the probability of rapid symptom return after CSU treatment discontinuation, which could improve the management of patients with CSU in the clinic. Omalizumab for the Treatment of Solar Urticaria: Case Series and Systematic Review of the Literature Snast et al 1198 What is already known about this topic? Solar urticaria (SU) is a rare type of inducible urticaria appearing within minutes of sunlight exposure. Although most patients can control the disease with antihistamines and leukotriene antagonists, a minority of patients require third-line therapies. What does this article add to our knowledge? Treatment with omalizumab resulted in clinical improvement for 80% of patients with antihistamine refractory SU, and 50% of patients became symptom free. Patients who fail to improve on standard omalizumab dose may benefit from higher monthly dosages. How does this study impact current management guidelines? This study highlights the efficacy and safety of omalizumab in the treatment of antihistamine refractory SU. Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema Andrási et al 1205 What is already known about this topic? The current classification of angioedema without wheals distinguishes 4 acquired and 3 hereditary forms of the disease. Idiopathic nonhistaminergic acquired angioedema (InH-AAE) and hereditary angioedema with unknown origin (U-HAE) could be difficult to diagnose. What does this article add to our knowledge? This is the first study comparing the clinical symptoms of InH-AAE and U-HAE seen in 2 separate patient populations with those of C1-INH-HAE. How does this study impact current management guidelines? The clinical pictures of InH-AAE and U-HAE were similar; however, these 2 disease forms were different from C1-INH-HAE, but the disease burden was similar in these 3 types of angioedema. 23A

2 24A JULY/AUGUST 2018 Hereditary Angioedema with Normal C1 Inhibitor and F12 Mutations in 42 Brazilian Families Veronez et al 1209 What is already known about this topic? Hereditary angioedema (HAE) with mutations in the F12 gene (FXII-HAE) is a rare genetic disease with characteristics similar to those of angioedema with C1 inhibitor deficiency, which mainly affects female patients, increasing the expression and severity of symptoms. What does this article add to our knowledge? The higher frequency of symptomatic male patients in the Brazilian population suggests that the gender penetrance previously described for FXII-HAE should be reconsidered. We report the highest number of families with FXII-HAE outside the European continent. How does this study impact current management guidelines? Our results demonstrate the usefulness of genetic testing to diagnose patients presenting with clinical features of HAE with normal C1 inhibitor, including male patients, even in the absence of a family history or estrogen influence. Risk of Immediate-Type Allergy to Local Anesthetics Is Overestimated Results from 5 Years of Provocation Testing in a Danish Allergy Clinic Kvisselgaard et al 1217 What is already known about this topic? Immediate-type allergy to local anesthetics (LAs) is considered rare by allergists. However, many health care professionals and patients still overestimate the risk of immediate-type LA allergy and potential cross-reactivity. What does this article add to our knowledge? Immediate-type allergy to LAs is extremely rare. Reactions most commonly have another nonallergic mechanism such as vasovagal reactions, or are caused by other simultaneous exposures such as chlorhexidine and latex, which should always be coinvestigated. How does this study impact current management guidelines? Skin testing with LAs may be false positive and should always be followed by subcutaneous provocation. Low-risk patients may be managed with placebo-controlled subcutaneous provocation with the culprit LA without prior skin testing. Acetyl Salicylic Acid Challenge in Children with Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs Differentiates Between Cross-Intolerant and Selective Responders Blanca-López et al 1226 What is already known about this topic? In adults several phenotypes of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs are recognized. They can be cross-intolerant or selective. Within the cross-intolerant, 3 subtypes are well differentiated with respiratory or cutaneous manifestations. What does this article add to our knowledge? Different phenotypes of cross-intolerant reactions in children are observed after confirmation by acetyl salicylic acid challenge. Following skin involvement, the most common association was respiratory plus cutaneous; isolated respiratory symptoms were infrequent. How does this study impact current management guidelines? In children with a history of hypersensitivity reactions to nonsteroidal antiinflammatory drugs, the administration of acetyl salicylic acid is the most appropriate initial way to establish the diagnosis. Successful Intravenous Immunoglobulin Treatment in Pediatric Severe DRESS Syndrome Marcus et al 1238 What is already known about this topic? Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe cutaneous and systemic delayed drug reaction. The treatment consists of withdrawal of the offending drug, and in severe cases, corticosteroids are added. The treatment of steroid-resistant cases is unclear. What does this article add to our knowledge? We describe 7 pediatric patients with severe DRESS syndrome who were treated successfully with intravenous immunoglobulin (IVIG) with minimal side effects. How does this study impact current management guidelines? IVIG treatment may hasten recovery in pediatric patients with severe DRESS syndrome, especially in patients with a severe course not responding to steroid treatment. Skin Testing for Suspected Iodinated Contrast Media Hypersensitivity Schrijvers et al 1246 What is already known about this topic? A subgroup of iodinated contrast medium (ICM) hypersensitivity reactions is immunologically mediated, potentially life threatening, and can be diagnosed using skin testing. Skin testing is preferred early (1-6 months) after the event. However, the negative predictive value of skin testing is insufficiently evaluated. What does this article add to our knowledge? Skin testing for potential ICM hypersensitivity can identify safe alternative(s) for reexposure, especially in patients with a history of an immediate hypersensitivity reaction. Reactions on re-exposure are infrequent and mostly milder.

3 VOLUME 6, NUMBER 4 25A How does this study impact current management guidelines? Our work validates the role of skin testing to identify safe alternatives and offers an allergologist-driven, clinical history-, and skin-test-based approach to guide ICM re-exposure, without the need for provocation testing outside an imaging context. Bioavailability and Cardiovascular Effects of Adrenaline Administered by Anapen Autoinjector in Healthy Volunteers Duvauchelle et al 1257 What is already known about this topic? Adrenaline autoinjectors used in anaphylaxis should have a sufficient needle length to reach the muscle. Their performance was analyzed using a novel combination of ultrasonography, adrenaline plasma level assays, and cardiovascular responses in human volunteers. What does this article add to our knowledge? Subcutaneous as well as intramuscular adrenaline, delivered using an autoinjector with a relatively short needle, may ensure optimal bioavailability and cardiovascular response, even in overweight women. The analysis of early bioavailability parameters and cardiovascular response is necessary to assess the speed of action of the devices. How does this study impact current management guidelines? The prediction of adrenaline autoinjector efficacy in anaphylaxis should be based on the combined assessment of ultrasonographic depot localization, the analysis of biphasic and parallel patterns of plasma adrenaline levels, and the cardiovascular responses in various categories of healthy volunteers. Utility of Risk Stratification for Paclitaxel Hypersensitivity Reactions Otani et al 1266 What is already known about this topic? Paclitaxel hypersensitivity reactions (HSRs) can be managed by reexposure with or without additional premedications and/or a slower infusion rate, or desensitization. Safe, effective risk stratification strategies are needed to identify patients who can tolerate reexposure without desensitization and patients who need desensitization. What does this article add to our knowledge? The severity of the initial HSR can be used to safely risk stratify patients to reexposure with additional premedications and a slower infusion rate, or desensitization. How does this study impact current management guidelines? A management strategy where the initial risk stratification is based on the severity of the initial HSR can be used to safely reintroduce patients to paclitaxel over consecutive dosing. Impact of Rhinitis on Work Productivity: A Systematic Review Vandenplas et al 1274 What is already known about this topic? Information on the economic impact of allergic rhinitis on work productivity remains fragmented and therefore cannot be taken efficiently into account by the medical community and policy makers. What does this article add to our knowledge? This systematic review confirms that rhinitis impacts at-work productivity more than absenteeism and provides a summary estimate that may serve as guidance for physicians and public health interventions. How does this study impact current management guidelines? Physicians should draw more attention to the burden of allergic rhinitis on work productivity, and inform the patient of the possible occupational impacts of the condition and the benefits of treatment. The Combined Utility of Ex Vivo IFN-g Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions Trubiano et al 1287 What is already known about this topic? The individual use of in vivo skin testing and ex vivo IFN-g release enzyme-linked immunospot (ELISpot) assay for assigning drug causality in severe cutaneous adverse reactions (SCARs) shows promise, yet the joint utility in antibiotic-associated SCARs remains ill-defined. What does this article add to our knowledge? The combined use of in vivo and ex vivo diagnostics in antibiotic-associated SCARs assigned causality safely in 79% of cases, and IFN-g release ELISpot assay demonstrated good sensitivity and high specificity. How does this study impact current management guidelines? Skin testing (in vivo) and IFN-g release ELISpot assay (ex vivo) are complementary approaches that may prove safe and effective in ascertaining antibiotic causality and improve, often difficult antibiotic prescribing, after SCARs.

4 26A JULY/AUGUST 2018 Clinical Phenotypes of Nasal Polyps and Comorbid Asthma Based on Cluster Analysis of Disease History Wu et al 1297 What is already known about this topic? Nasal polyps and comorbid asthma is a common unified airway disease. What does this article add to our knowledge? Nasal polyps and comorbid asthma exhibits 3 clinical phenotypes with distinct natural courses. How does this study impact current management guidelines? Identification of phenotypes of nasal polyps and comorbid asthma might be diagnostically and therapeutically useful. Phenotypical Differences of Childhood- and Adult-Onset Atopic Dermatitis Silverberg et al 1306 What is already known about this topic? The risk factors and clinical characteristics of adult-onset atopic dermatitis are poorly understood. What does this article add to our knowledge? Adults with atopic dermatitis have high rates of self-reported adult-onset atopic dermatitis, lower prevalence of personal or family history of atopic disease, and distinct phenotypes with less flexural lesions and more involvement of the hands and/or head/neck. How does this study impact current management guidelines? Clinicians caring for patients with atopic dermatitis should recognize the phenotypes associated with adult-onset atopic dermatitis. Further studies are needed to determine whether these phenotypes are associated with different treatment outcomes. The Value of Fractional Exhaled Nitric Oxide and Forced Mid-Expiratory Flow as Predictive Markers of Bronchial Hyperresponsiveness in Adults with Chronic Cough Bao et al 1313 What is already known about this topic? Small-airway dysfunction contributes to the pathophysiology of even the mildest forms of classical asthma. It may exist in cough-variant asthma, and its presence could be helpful in predicting bronchial hyperresponsiveness (BHR). What does this article add to our knowledge? Small-airway dysfunction is present in patients with chronic cough and BHR. Forced expiratory flow between 25% and 75% (FEF 25%-75% ) can be used to predict BHR when combined with fractional exhaled nitric oxide (FENO). How does this study impact current management guidelines? FENO > 43 ppb and FEF 25%-75% < 78.5% strongly predicted positive BHR in Chinese patients. This method is more accessible and convenient than bronchial provocation tests, especially for doctors in primary hospitals. Natural History of Benign Nonimmediate Allergy to Beta-Lactams in Children: A Prospective Study in Retreated Patients After a Positive and a Negative Provocation Test Tonson la Tour et al 1321 What is already known about this topic? Although it has been shown that the sensitivity to beta-lactams (BL) decreases over time in patients with an immediate hypersensitivity, data are lacking regarding the natural history of nonimmediate hypersensitivity to BL. What does this article add to our knowledge? Our results showed that the vast majority of children (89%) with benign nonimmediate BL allergy become tolerant after 3 years. From another point of view, the negative predictive value of the drug provocation test (DPT) using a 2-day protocol was 96.7%. How does this study impact current management guidelines? Our data strongly suggest that a follow-up DPT is safe and useful to assess tolerance acquisition in children with nonimmediate BL allergy. In addition, our data support the use of a 2-day protocol DPT. Longitudinal Evaluation of Chronic Rhinosinusitis Symptoms in a Population-Based Sample Sundaresan et al 1327 What is already known about this topic? Chronic rhinosinusitis (CRS) is a prevalent and disabling condition of the nose and sinuses. It is a heterogeneous disease, with various symptom combinations. Its natural history in the general population has not been previously studied. What does this article add to our knowledge? Less than half with symptoms meeting CRS European Position Paper on Rhinosinusitis epidemiologic criteria were stable over a 6-month time period in the general population. Multiple and severe symptoms and earlier age of onset predict disease persistence, and not treatment.

5 VOLUME 6, NUMBER 4 27A How does this study impact current management guidelines? CRS symptoms have high lifetime prevalence. Symptom profiles at baseline were associated with change in symptoms over 6 months. Understanding this variation could lead to better understanding of CRS phenotypes and management. Food Allergy Is an Important Risk Factor for Childhood Asthma, Irrespective of Whether It Resolves Vermeulen et al 1336 What is already known about this topic? Allergic sensitization, including food sensitization, is positively associated with asthma or respiratory symptoms; however, the role of clinical food allergy in this relationship has not been explored at the population level. What does this article add to our knowledge? This article provides evidence that oral food challengeeconfirmed food allergy in infancy is associated with an increased risk of asthma at the age of 4 years irrespective of whether the early food allergy resolves. The risk is higher for those with multiple food allergies and those with coexistent eczema. How does this study impact current management guidelines? This data can be used by clinicians to inform families of children with food allergies about their child s risk of developing asthma in early childhood, and to identify children who may need closer follow-up and monitoring of their respiratory health. Understanding whether the prevention of early life food allergy prevents the development of later asthma will be an important challenge for the future. Health Care Resource Utilization and Costs Among Adults with Atopic Dermatitis in the United States: A Claims-Based Analysis Drucker et al 1342 What is already known about this topic? Atopic dermatitis (AD) is associated with significant direct medical costs but updated estimates are needed. What does this article add to our knowledge? Adjusted incremental annual direct costs for patients with AD in this US study were $3,302. Costs are higher in patients with more severe disease. How does this study impact current management guidelines? Patients, clinicians, and payers should be aware of the costs associated with AD and factor these into clinical decision making. Use of a Penicillin Allergy Screening Algorithm and Penicillin Skin Testing for Transitioning Hospitalized Patients to First-Line Antibiotic Therapy Ramsey et al 1349 What is already known about this topic? The penicillin allergy label has significant public health implications. Different inpatient approaches at academic centers addressing this problem include skin testing by pharmacists or infectious disease providers, and an algorithm to direct cephalosporin challenges. What does this article add to our knowledge? This article describes an allergy/pharmacist antimicrobial stewardship initiative in which patients were identified for inpatient penicillin skin testing based on high-risk, second-line antibiotic use in a community hospital setting. How does this study impact current management guidelines? This study provides another approach for penicillin allergy de-labeling, which is in line with multiple national guidelines. Assessment of Antihistamines and Corticosteroids as Premedication in Rapid Drug Desensitization to Paclitaxel: Outcomes in 155 Procedures Lopez-Gonzalez et al 1356 What is already known about this topic? Rapid drug desensitization is a helpful therapeutic tool that enables paclitaxel to be safely administered to paclitaxel-hypersensitive patients. What does this article add to our knowledge? It is unclear whether systematic premedication with antihistamines and corticosteroids makes rapid drug desensitization to paclitaxel safer. How does this study impact current management guidelines? Premedication regimens for rapid drug desensitization may be increasingly tailored to prevent adverse effects from unnecessary systematic administration of drugs. Asthma, Family History of Drug Allergy, and Age Predict Amoxicillin Allergy in Children Faitelson et al 1363 What is already known about this topic? To date, physicians are unable to predict who will fail or pass oral graded challenge with amoxicillin, which is commonly used to rule out alleged amoxicillin allergy in children. What does this article add to our knowledge? The presence of asthma, family history of drug allergy, and older age at reaction are associated with a higher risk of failing the oral challenge. Skin prick test was not helpful in diagnosing amoxicillin allergy.

6 28A JULY/AUGUST 2018 How does this study impact current management guidelines? Recognizing risk factors for amoxicillin allergy in the pediatric population can assist the allergist in deciding what will be the optimal setting of an oral challenge for individual patients. Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected Bonadonna et al 1368 What is already known about this topic? There are no data on the presence and prevalence of mastocytosis in patients who experience severe reactions from Hymenoptera stings after the termination of an effective venom immunotherapy (VIT) course. What does this article add to our knowledge? Mastocytosis should be suspected in those patients with Hymenoptera allergy who experience severe reactions and anaphylaxis after stopping VIT that had been previously protective. How does this study impact current management guidelines? A proper diagnostic procedure for mastocytosis should be considered in patients developing severe reactions at re-sting after VIT discontinuation. VIT should therefore be continued lifelong in subjects with mastocytosis and venom allergy. Antituberculosis Drug-Associated DRESS: A Case Series Allouchery et al 1373 What is already known about this topic? Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare but potentially lifethreatening adverse drug reaction. Antituberculosis drugs are not commonly associated with DRESS. What does this article add to our knowledge? We described 67 cases of antituberculosis drug-associated DRESS. Liver, kidneys, and bone marrow were the most frequently involved organs. The use of systemic corticosteroids was not associated with a flare of underlying tuberculosis infection. How does this study impact current management guidelines? The diagnosis of antituberculosis drug-associated DRESS should not be dismissed. A drug allergy evaluation must be performed to optimize the second-line treatment of tuberculosis infection.

Clinical Implications of Asthma Phenotypes. Michael Schatz, MD, MS Department of Allergy

Clinical Implications of Asthma Phenotypes. Michael Schatz, MD, MS Department of Allergy Clinical Implications of Asthma Phenotypes Michael Schatz, MD, MS Department of Allergy Definition of Phenotype The observable properties of an organism that are produced by the interaction of the genotype

More information

UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE. Plan of the course. Basics of Pediatric Allergy. Academic year 2015/2016. Mirjana Turkalj

UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE. Plan of the course. Basics of Pediatric Allergy. Academic year 2015/2016. Mirjana Turkalj UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE Plan of the course Basics of Pediatric Allergy Academic year 2015/2016 I. COURSE AIMS COURSE OUTLINE The specialty of allergy involves the management of a wide range

More information

contact activation in formation diseases 67 endothelial cells and kinin formation 73 processing and degradation 68 70

contact activation in formation diseases 67 endothelial cells and kinin formation 73 processing and degradation 68 70 Subject Index Adenosine, mast cell activation modulation 60 Age, risk factor 17, 18 Allergen elicitors 9, 10 insects, see Insect venom-induced microarrays for 136 overview of characteristics 23 recognition

More information

IMMUNOLOGY. Referral Guidelines NATIONAL REFERRAL GUIDELINES : IMMUNOLOGY. As above Specialist assessment is essential.

IMMUNOLOGY. Referral Guidelines NATIONAL REFERRAL GUIDELINES : IMMUNOLOGY. As above Specialist assessment is essential. PAGE 1 IMMUNOLOGY National PRIMARY IMMUNODEFICIENCY Primary immunodeficiency should be suspected in any patient with recurrent or persistent infection or unusual infection. Recurrent sinopulmonary infections

More information

Antibiotic allergy in the Intensive Care. Sanjay Swaminathan Clinical Immunologist, Westmead and Blacktown Hospitals September 28, 2017

Antibiotic allergy in the Intensive Care. Sanjay Swaminathan Clinical Immunologist, Westmead and Blacktown Hospitals September 28, 2017 Antibiotic allergy in the Intensive Care Sanjay Swaminathan Clinical Immunologist, Westmead and Blacktown Hospitals September 28, 2017 Outline of talk True or false? Case example Types of drug allergy

More information

Anti-IgE: beyond asthma

Anti-IgE: beyond asthma Anti-IgE: beyond asthma Yehia El-Gamal, MD, PhD, FAAAAI Professor of Pediatrics Pediatric Allergy and Immunology Unit Children s Hospital, Ain Shams University Member, WAO Board of Directors Disclosure

More information

7/25/2016. Use of Epinephrine in the Community. Knowledge Amongst Paramedics. Knowledge Amongst Paramedics survey of 3479 paramedics

7/25/2016. Use of Epinephrine in the Community. Knowledge Amongst Paramedics. Knowledge Amongst Paramedics survey of 3479 paramedics Recognition & Management of Anaphylaxis in the Community S. Shahzad Mustafa, MD, FAAAAI Disclosures Speaker s bureau Genentech, Teva Consultant Genentech, Teva Outline Knowledge gap Definition Pathophysiology

More information

INVESTIGATIONS & PROCEDURES IN PULMONOLOGY. Immunotherapy in Asthma Dr. Zia Hashim

INVESTIGATIONS & PROCEDURES IN PULMONOLOGY. Immunotherapy in Asthma Dr. Zia Hashim INVESTIGATIONS & PROCEDURES IN PULMONOLOGY Immunotherapy in Asthma Dr. Zia Hashim Definition Involves Administration of gradually increasing quantities of specific allergens to patients with IgE-mediated

More information

Urticaria and Angioedema. Allergy and Immunology Awareness Program

Urticaria and Angioedema. Allergy and Immunology Awareness Program Urticaria and Angioedema Allergy and Immunology Awareness Program 1 Urticaria and Angioedema Allergy and Immunology Awareness Program Urticaria Commonly known as hives, urticarial is an itchy rash with

More information

Drug Allergy A Guide to Diagnosis and Management

Drug Allergy A Guide to Diagnosis and Management Drug Allergy A Guide to Diagnosis and Management (Version 1 April 2015 updated April 2018) Author: Jed Hewitt Chief Pharmacist, Governance & Professional Practice Date of Preparation: April 2015 Updated:

More information

Drug allergy and Skin Disorders. Timothy Craig, DO, FACOI Professor of Medicine and Pediatrics Distinguished Educator Penn State University, Hershey

Drug allergy and Skin Disorders. Timothy Craig, DO, FACOI Professor of Medicine and Pediatrics Distinguished Educator Penn State University, Hershey Drug allergy and Skin Disorders Timothy Craig, DO, FACOI Professor of Medicine and Pediatrics Distinguished Educator Penn State University, Hershey The best screening test for anaphylaxis is? A. histamine

More information

Management of drug allergy

Management of drug allergy Management of drug allergy PART II Outline 1 2 3 General management Beta lactam allergy NSAIDs allergy General management Refer to allergist for confirm or find safe alternative drug Especially 1. Beta-lactam

More information

An Insight into Allergy and Allergen Immunotherapy Co-morbidities of allergic disease

An Insight into Allergy and Allergen Immunotherapy Co-morbidities of allergic disease An Insight into Allergy and Allergen Immunotherapy Co-morbidities of allergic disease Carmen Vidal Athens, September 11, 2014 Pucci S & Incorvaia C, 2008; 153:1-2 1. The major player in driving the immune

More information

8/8/2016. Overview. Back to Basics: Immunology. Adverse Reactions to Drugs: Dispelling Myths

8/8/2016. Overview. Back to Basics: Immunology. Adverse Reactions to Drugs: Dispelling Myths Adverse Reactions to Drugs: Dispelling Myths Allison Ramsey, MD NPA Annual Conference September 30, 2016 Overview Review of types of hypersensitivity reactions Penicillin allergy IV contrast allergy Local

More information

ANAPHYLAXIS IN ANESTHESIA

ANAPHYLAXIS IN ANESTHESIA ANAPHYLAXIS IN ANESTHESIA Content I. Definition II. Epidemiology III. Etiology IV. Recognition V. Diagnosis VI. Observation and follow up VII.Drugs Definition Prophylaxis : protection Anaphylaxis : against

More information

Allergy/Immunology Marshall University Pediatrics

Allergy/Immunology Marshall University Pediatrics Allergy/Immunology Marshall University Pediatrics Description: This is a clinical rotation about the most common chronic diseases affecting both children and adults. Residents will be introduced to allergy,

More information

(Asthma) Diagnosis, monitoring and chronic asthma management

(Asthma) Diagnosis, monitoring and chronic asthma management Dubai Standards of Care 2018 (Asthma) Diagnosis, monitoring and chronic asthma management Preface Asthma is one of the most common problem dealt with in daily practice. In Dubai, the management of chronic

More information

COMMISSIONING POLICY RECOMMENDATION TREATMENT ADVISORY GROUP Policy agreed by North Lincolnshire CCG November 2012

COMMISSIONING POLICY RECOMMENDATION TREATMENT ADVISORY GROUP Policy agreed by North Lincolnshire CCG November 2012 Drug, Treatment, Device name Omalizumab (Xolair; Novartis) COMMISSIONING POLICY RECOMMENDATION TREATMENT ADVISORY GROUP Policy agreed by North Lincolnshire CCG November 2012 Licensed indication Omalizumab

More information

Persia Pourshahnazari MD, FRCPC Clinical Immunology and Allergy November 3, 2018

Persia Pourshahnazari MD, FRCPC Clinical Immunology and Allergy November 3, 2018 Persia Pourshahnazari MD, FRCPC Clinical Immunology and Allergy November 3, 2018 UBC couldn t get rid of me Medical school, Internal Medicine residency, Clinical Immunology and Allergy fellowship Current

More information

By the end of this lecture physicians will:

By the end of this lecture physicians will: No disclosure By the end of this lecture physicians will: 1. Be able to identify patients who need immune work-up. 2. Be able to recognize the manifestation of food allergies. 3. Be knowledgeable about

More information

Choosing a Path in Allergy and Clinical Immunology

Choosing a Path in Allergy and Clinical Immunology Sandra Nora Gonzalez Diaz, MD, PhD. Choosing a Path in Allergy and Clinical Immunology ACADEMIC PRACTICE Allergic Diseases as a Global Public Health Issue According to World Health Organization (WHO) statistics

More information

Allergic Disorders Interface with Ear, Nose, and Throat Disorders B.J. Ferguson and Suman Golla

Allergic Disorders Interface with Ear, Nose, and Throat Disorders B.J. Ferguson and Suman Golla Allergies for the Otolaryngologist Allergic Disorders Interface with Ear, Nose, and Throat Disorders B.J. Ferguson and Suman Golla xv The Evolution of Understanding Inhalant Allergy 519 J. David Osguthorpe

More information

Xolair. Xolair (omalizumab) Description

Xolair. Xolair (omalizumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.45.02 Subject: Xolair Page: 1 of 6 Last Review Date: March 18, 2016 Xolair Description Xolair (omalizumab)

More information

PedsCases Podcast Scripts

PedsCases Podcast Scripts PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on Drug Allergy. These podcasts are designed to give medical students an overview of key topics in pediatrics. The audio

More information

Xolair. Xolair (omalizumab) Description

Xolair. Xolair (omalizumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.45.02 Subject: Xolair Page: 1 of 7 Last Review Date: September 15, 2016 Xolair Description Xolair (omalizumab)

More information

Chapter 65 Allergy and Immunology for the Internist. ingestion provoke an IgE antibody response and clinical symptoms in sensitive individuals.

Chapter 65 Allergy and Immunology for the Internist. ingestion provoke an IgE antibody response and clinical symptoms in sensitive individuals. Chapter 65 Allergy and Immunology for the Internist 1 I. Basic Information A. Definition of Allergens: Proteins of appropriate size that after inhalation, injection (e.g. drug, venom) or ingestion provoke

More information

Idiopathic Anaphylaxis. Paul A. Greenberger, MD, FAAAAI 2/28/2014 Course # 1605

Idiopathic Anaphylaxis. Paul A. Greenberger, MD, FAAAAI 2/28/2014 Course # 1605 Idiopathic Anaphylaxis Paul A. Greenberger, MD, FAAAAI 2/28/2014 Course # 1605 Objectives Review definition and classification of idiopathic anaphylaxis Consider the differential diagnosis Critique lab

More information

Global Initiative for Asthma (GINA) What s new in GINA 2017?

Global Initiative for Asthma (GINA) What s new in GINA 2017? Global Initiative for Asthma (GINA) GINA Global Strategy for Asthma Management and Prevention Asthma-COPD overlap The word syndrome has been removed from the previous term asthma-copd overlap syndrome

More information

Corporate Medical Policy Allergy Immunotherapy (Desensitization)

Corporate Medical Policy Allergy Immunotherapy (Desensitization) Corporate Medical Policy Allergy Immunotherapy (Desensitization) File Name: Origination: Last CAP Review: Next CAP Review: Last Review: allergy_immunotherapy 7/1979 11/2017 11/2018 11/2017 Description

More information

Asthma: diagnosis and monitoring

Asthma: diagnosis and monitoring Asthma: diagnosis and monitoring NICE guideline: short version Draft for second consultation, July 01 This guideline covers assessing, diagnosing and monitoring suspected or confirmed asthma in adults,

More information

IMMUNOTHERAPY IN ALLERGIC RHINITIS

IMMUNOTHERAPY IN ALLERGIC RHINITIS Rhinology research Chair Weekly Activity, King Saud University IMMUNOTHERAPY IN ALLERGIC RHINITIS E V I D E N C E D - B A S E O V E R V I E W O F T H E R U L E O F I M M U N O T H E R A P Y I N A L L E

More information

Hypersensitivity diseases

Hypersensitivity diseases Hypersensitivity diseases Downloaded from: StudentConsult (on 18 July 2006 11:40 AM) 2005 Elsevier Type-I Hypersensitivity Basic terms Type-I = Early= IgE-mediated = Atopic = Anaphylactic type of hypersensitivity

More information

Xolair (Omalizumab) Drug Prior Authorization Protocol (Medical Benefit & Part B Benefit)

Xolair (Omalizumab) Drug Prior Authorization Protocol (Medical Benefit & Part B Benefit) Line of Business: All Lines of Business Effective Date: August 16, 2017 Xolair (Omalizumab) Drug Prior Authorization Protocol (Medical Benefit & Part B Benefit) This policy has been developed through review

More information

Coverage Criteria: Express Scripts, Inc. monograph dated 03/03/2010

Coverage Criteria: Express Scripts, Inc. monograph dated 03/03/2010 BENEFIT DESCRIPTION AND LIMITATIONS OF COVERAGE ITEM: PRODUCT LINES: COVERED UNDER: DESCRIPTION: CPT/HCPCS Code: Company Supplying: Setting: Xolair (omalizumab) Commercial HMO/PPO/CDHP HMO/PPO/CDHP: Rx

More information

MANAGING COMMON PRESENTATIONS OF ALLERGY IN PRIMARY CARE. Helen Bourne Consultant Immunologist

MANAGING COMMON PRESENTATIONS OF ALLERGY IN PRIMARY CARE. Helen Bourne Consultant Immunologist MANAGING COMMON PRESENTATIONS OF ALLERGY IN PRIMARY CARE Helen Bourne Consultant Immunologist AIMS Presentation of Allergic Disease in Adults Rhinitis/ Rhinoconjuctivitis Urticaria and Angioedema Food

More information

Management of Chronic Idiopathic Urticaria

Management of Chronic Idiopathic Urticaria 9/3/216 Management of Chronic Idiopathic Urticaria Brian Berman, M.D., Ph.D. Professor Emeritus of Dermatology and Dermatologic Surgery, University of Miami Co-Director Center for Clinical and Cosmetic

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal (STA)

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal (STA) Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology

More information

Public Dissemination

Public Dissemination 1. THE ASTHMA CONDITION 9 18 3 30 A. Pathophysiology 4 6 0 10 1. Teach an individual with asthma and their family using simple language by illustrating the following with appropriate educational aids a.

More information

Skin prick testing: Guidelines for GPs

Skin prick testing: Guidelines for GPs INDEX Summary Offered testing but where Allergens precautions are taken Skin prick testing Other concerns Caution Skin testing is not useful in these following conditions When skin testing is uninterpretable

More information

Managing Penicillin Allergy

Managing Penicillin Allergy Managing Penicillin Allergy Brian T. Kelly, MD MA April 12, 2019 Objectives Review penicillin allergy prevalence, morbidity, and management Describe the penicillin testing and oral challenge process Provide

More information

National Asthma Educator Certification Board Detailed Content Outline

National Asthma Educator Certification Board Detailed Content Outline I. THE ASTHMA CONDITION 9 20 1 30 A. Pathophysiology 4 6 0 10 1. Teach an individual with asthma and their family using simple language by illustrating the following with appropriate educational aids a.

More information

Omalizumab (Xolair ) ( Genentech, Inc., Novartis Pharmaceuticals Corp.) September Indication

Omalizumab (Xolair ) ( Genentech, Inc., Novartis Pharmaceuticals Corp.) September Indication ( Genentech, Inc., Novartis Pharmaceuticals Corp.) September 2003 Indication The FDA recently approved Omalizumab on June 20, 2003 for adults and adolescents (12 years of age and above) with moderate to

More information

Anti-allergic Effect of Bee Venom in An Allergic Rhinitis

Anti-allergic Effect of Bee Venom in An Allergic Rhinitis Anti-allergic Effect of Bee Venom in An Allergic Rhinitis Dr: Magdy I. Al-Shourbagi Sharm International Hospital Allergic Rhinitis Rhinitis: Symptomatic disorder of the nose characterized by itching, nasal

More information

Diagnosis and management of suspected drug allergies

Diagnosis and management of suspected drug allergies Diagnosis and management of suspected drug allergies SPL Sophie Farooque MRCP Allergic reactions can be caused by commonly prescribed drugs and can lead to fatal anaphylaxis. Here, the author describes

More information

Antiallergics and drugs used in anaphylaxis

Antiallergics and drugs used in anaphylaxis Antiallergics and drugs used in anaphylaxis Antiallergics and drugs used in anaphylaxis The H 1 -receptor antagonists are generally referred to as antihistamines. They inhibit the wheal, pruritus, sneezing

More information

Mast Cell Mediators. Updates on Chronic Urticaria 11/1/2016. Urticaria: What happens in the skin?

Mast Cell Mediators. Updates on Chronic Urticaria 11/1/2016. Urticaria: What happens in the skin? Urticaria: What happens in the skin? Updates on Chronic Urticaria Kent Woo, MD (USA) Allergy/Immunology Internal Medicine C A U S E MC, mast cell IgE Fc eri MC Release of Mediators Activation Vasodilation

More information

Anaphylaxis School First results of a national multicenter study

Anaphylaxis School First results of a national multicenter study Anaphylaxis School First results of a national multicenter study J. Kupfer, S. Schallmayer, I. Fell, U. Gieler for the German study group Anaphylaxis is an acute, potentially life-threatening hypersensitivity

More information

Skin testing with β-lactam antibiotics for diagnosis of β-lactam hypersensitivity in children

Skin testing with β-lactam antibiotics for diagnosis of β-lactam hypersensitivity in children Asian Pacific Journal of Allergy and Immunology ORIGINAL ARTICLE Skin testing with β-lactam antibiotics for diagnosis of β-lactam hypersensitivity in children Wiparat Manuyakorn, 1 Prapasiri Singvijarn,

More information

Scope of Practice Allergy Skin Testing in Australia In relation to revised Medicare Benefits Schedule item numbers effective 1 November 2018

Scope of Practice Allergy Skin Testing in Australia In relation to revised Medicare Benefits Schedule item numbers effective 1 November 2018 Scope of Practice Allergy Skin Testing in Australia In relation to revised Medicare Benefits Schedule item numbers effective 1 November 2018 A. Introduction The Australasian Society of Clinical Immunology

More information

Michaela Lucas. Clinical Immunologist/Immunopathologist. Pathwest, QE2 Medical Centre, Princess Margaret Hospital

Michaela Lucas. Clinical Immunologist/Immunopathologist. Pathwest, QE2 Medical Centre, Princess Margaret Hospital Michaela Lucas Clinical Immunologist/Immunopathologist Pathwest, QE2 Medical Centre, Princess Margaret Hospital School of Medicine and Pharmacology, School of Pathology and Laboratory Medicine University

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Xolair (omalizumab) Page 1 of 15 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Xolair (omalizumab) Prime Therapeutics will review Prior Authorization requests.

More information

Product Information BROWN SNAKE ANTIVENOM AUST R 74897

Product Information BROWN SNAKE ANTIVENOM AUST R 74897 Product Information APPROVED NAME BROWN SNAKE ANTIVENOM AUST R 74897 DESCRIPTION BROWN SNAKE ANTIVENOM is prepared from the plasma of horses immunised with the venom of the brown snake (Pseudonaja textilis).

More information

G Glycopeptides, Glycosylation, 360

G Glycopeptides, Glycosylation, 360 A Aaphylactoid reaction, 14 ACE inhibitor-related angioedema, 33 Acute allergic reactions, 29 31 Acute coronary syndromes, 201 AERD. See Aspirin-exacerbated respiratory disease Allergy, food. See Food

More information

Allergy Skin Prick Testing

Allergy Skin Prick Testing Allergy Skin Prick Testing What is allergy? The term allergy is often applied erroneously to a variety of symptoms induced by exposure to a wide range of environmental or ingested agents. True allergy

More information

Food-allergy-FINAL.mp3. Duration: 0:07:39 START AUDIO

Food-allergy-FINAL.mp3. Duration: 0:07:39 START AUDIO BMJ LEARNING VIDEO TRANSCRIPT File: Duration: 0:07:39 Food-allergy-FINAL.mp3 START AUDIO Adam Fox: Food allergy is an inappropriate immune response to food. Our immune systems should ignore food completely,

More information

Ailléirge Péidiatraiceach. Pediatric Allergy 3/9/2018. Disclosures & Conflicts Of Interest

Ailléirge Péidiatraiceach. Pediatric Allergy 3/9/2018. Disclosures & Conflicts Of Interest Ailléirge Péidiatraiceach Michael Zacharisen, M.D. Allergy/Immunology Pediatric Allergy Michael Zacharisen, M.D. Allergy/Immunology Disclosures & Conflicts Of Interest Green Bay Packer fan I drive a Jeep

More information

Eosinophilic Esophagitis (EoE)

Eosinophilic Esophagitis (EoE) Eosinophilic Esophagitis (EoE) 01.06.2016 EoE: immune-mediated disorder food or environmental antigens => Th2 inflammatory response. Key cytokines: IL-4, IL-5, and IL-13 stimulate the production of eotaxin-3

More information

HAE disease fact sheet

HAE disease fact sheet [Insert organization logo and the hae day :-) logo] HAE disease fact sheet Hereditary Angioedema (HAE) is a rare, potentially life threatening inherited disorder with symptoms of severe, painful, and recurring

More information

Prevention and management of ASA/NSAID hypersensitivity

Prevention and management of ASA/NSAID hypersensitivity WISC 2012 Hydrabad, India PG Course, Dec 6, 2012 Prevention and management of ASA/NSAID hypersensitivity Hae- Sim Park, Professor Department of Allergy & Clinical Immunology Ajou University School of Medicine,

More information

Allergy Immunotherapy in the Primary Care Setting

Allergy Immunotherapy in the Primary Care Setting Allergy Immunotherapy in the Primary Care Setting New York State College Health Association 2008 COMBINED ANNUAL MEETING October 2008 Mary Madsen RN BC University of Rochester Issues in Primary Care Practice

More information

Recognition & Management of Anaphylaxis in the Community. S. Shahzad Mustafa, MD, FAAAAI

Recognition & Management of Anaphylaxis in the Community. S. Shahzad Mustafa, MD, FAAAAI Recognition & Management of Anaphylaxis in the Community S. Shahzad Mustafa, MD, FAAAAI Disclosures None Outline Define anaphylaxis Pathophysiology Common causes Recognition and Management Definition Acute,

More information

Five things to know about anaphylaxis

Five things to know about anaphylaxis Five things to know about anaphylaxis Magdalena Berger, MD FRCPC Allergist and Clinical Immunologist New Brunswick Internal Medicine Update April 22, 2016 Disclosures None relevant to this presentation

More information

BOLSTRAN Injection (Omalizumab)

BOLSTRAN Injection (Omalizumab) Published on: 27 Feb 2017 BOLSTRAN Injection (Omalizumab) Composition Active Substance Omalizumab is a humanized monoclonal antibody manufactured from a mammalian cell line. One vial of BOLSTRAN 150 mg

More information

Clinical Study Report SLO-AD-1 Final Version DATE: 09 December 2013

Clinical Study Report SLO-AD-1 Final Version DATE: 09 December 2013 1. Clinical Study Report RANDOMIZED, OPEN, PARALLEL GROUP, PHASE IIIB STUDY ON THE EVALUATION OF EFFICACY OF SPECIFIC SUBLINGUAL IMMUNOTHERAPY IN PAEDIATRIC PATIENTS WITH ATOPIC DERMATITIS, WITH OR WITHOUT

More information

ANTIBIOTICS ACUTE RHINOSINUSITIS IN CHILDREN

ANTIBIOTICS ACUTE RHINOSINUSITIS IN CHILDREN MARCH 2016 DRUG ANTIBIOTICS This optimal usage guide is mainly intended f primary care health professionnals. It is provided f infmation purposes only and should not replace the clinician s judgement.

More information

XOLAIR (omalizumab) Prior Authorization

XOLAIR (omalizumab) Prior Authorization MP9309 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes as shown below May only be prescribed by Allergy, Pulmonary, Immunology or Dermatology specialists

More information

NG80. Asthma: diagnosis, monitoring and chronic asthma management (NG80)

NG80. Asthma: diagnosis, monitoring and chronic asthma management (NG80) Asthma: diagnosis, monitoring and chronic asthma management (NG80) NG80 NICE has checked the use of its content in this product and the sponsor has had no influence on the content of this booklet. NICE

More information

ANGIOEDEMA WHAT YOU NEED TO KNOW

ANGIOEDEMA WHAT YOU NEED TO KNOW ANGIOEDEMA WHAT YOU NEED TO KNOW K I MBERLY HULL DO No relevant disclosures OBJECTIVES Review the etiologies of angioedema without urticaria Discuss the diagnostic approach to angioedema Discuss acute

More information

They re Scratching and You re Scratching Your Head: An Approach to the Diagnosis and Management of Acute and Chronic Urticaria

They re Scratching and You re Scratching Your Head: An Approach to the Diagnosis and Management of Acute and Chronic Urticaria They re Scratching and You re Scratching Your Head: An Approach to the Diagnosis and Management of Acute and Chronic Urticaria Adelle R. Atkinson, MD, FRCPC Sea Courses May/June 2017 Copyright 2017 by

More information

Adverse drug reactions

Adverse drug reactions Medications William Smith Adverse drug reactions Allergy? Side-effect? Intolerance? Background Adverse drug reactions (ADRs) vary from life-threatening anaphylaxis to minor common side-effects. Objective

More information

Rhinosinusitis. John Ramey, MD Joseph Russell, MD

Rhinosinusitis. John Ramey, MD Joseph Russell, MD Rhinosinusitis John Ramey, MD Joseph Russell, MD Disclosure Statement RSFH as a continuing medical education provider, accredited by the South Carolina Medical Association, it is the policy of RSFH to

More information

Seasonal Allergic Rhinoconjunctivitis

Seasonal Allergic Rhinoconjunctivitis Seasonal Allergic Rhinoconjunctivitis Allergic rhinoconjunctivitis is a common condition. Most patients can achieve good symptom control through allergen avoidance and pharmacotherapy with non-sedating

More information

Accelerated Immunotherapy Schedules: More Convenient? Just As Safe?

Accelerated Immunotherapy Schedules: More Convenient? Just As Safe? Accelerated Immunotherapy Schedules: More Convenient? Just As Safe? David A. Khan, MD Professor of Medicine Allergy & Immunology Training Program Director Division of Allergy & Immunology University of

More information

Allergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm

Allergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm Allergic Disorders Anne-Marie Irani, MD Virginia Commonwealth University Allergic Disorders IgE-mediated immune reactions Clinical entities include: asthma allergic rhinitis atopic dermatitis urticaria

More information

Allergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm

Allergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm Allergic Disorders Anne-Marie Irani, MD Virginia Commonwealth University Allergic Disorders IgE-mediated immune reactions Clinical entities include: asthma allergic rhinitis atopic dermatitis urticaria

More information

Perioperative Anaphylaxis. Aleena Banerji, MD AAAAI 2014 San Diego, California

Perioperative Anaphylaxis. Aleena Banerji, MD AAAAI 2014 San Diego, California Perioperative Anaphylaxis Aleena Banerji, MD AAAAI 2014 San Diego, California Objectives Better understand the differential diagnosis of perioperative anaphylaxis Evaluate and manage patients with a history

More information

Case 1: HPI. Case 1: PMHx + SHx. Case 1: PMHx + SHx. Case 1: Salient features of Examination. Case 2: Diagnosis and Management. Immunology Meeting

Case 1: HPI. Case 1: PMHx + SHx. Case 1: PMHx + SHx. Case 1: Salient features of Examination. Case 2: Diagnosis and Management. Immunology Meeting Case 1: HPI Immunology Meeting 50M found to have elevated LFT on routine bloods by GP Referred to Gastroenterologist who performed a liver screen and Hepatitis serology all normal- no cause for deranges

More information

Drug induced allergy and hypersensitivity

Drug induced allergy and hypersensitivity Drug induced allergy and hypersensitivity Yunita Sari Pane, Aznan Lelo Dept. Pharmacology & Therapeutic School of Medicine Universitas Sumatera Utara 13 Mei 2009, KBK-FK USU, Medan Drug Allergy Adverse

More information

Hymenoptera Venom Allergy. David F. Graft, M.D.

Hymenoptera Venom Allergy. David F. Graft, M.D. Hymenoptera Venom Allergy David F. Graft, M.D. Stinging Insect Hypersensitivity: A Practice Parameter Update 2010 * Chief Editors David B.K. Golden, MD, John Moffit, MD and Richard A. Nicklas, MD Work

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Xolair (omalizumab) Page 1 of 15 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Xolair (omalizumab) Prime Therapeutics will review Prior Authorization requests.

More information

GUIDELINES FOR WEIGHT-BASED DOSING AND INFUSION

GUIDELINES FOR WEIGHT-BASED DOSING AND INFUSION GUIDELINES FOR WEIGHT-BASED DOSING AND INFUSION Includes Example dose calculation wheel Preparation and administration information for healthcare professionals Please see enclosed full Prescribing Information,

More information

Biologic Therapy in the Management of Asthma. Nabeel Farooqui, MD

Biologic Therapy in the Management of Asthma. Nabeel Farooqui, MD Biologic Therapy in the Management of Asthma Nabeel Farooqui, MD None Disclosures Objectives Define severe asthma phenotypes and endotypes Describe the role of biologics in asthma management Review pivotal

More information

Adverse Drug Reactions. Navigating the World of. Adverse Drug Reactions. Definition. Essential History Taking. Essential History Taking

Adverse Drug Reactions. Navigating the World of. Adverse Drug Reactions. Definition. Essential History Taking. Essential History Taking Adverse Drug Reactions Navigating the World of Adverse Drug Reactions Jason Knuffman, M.D. Quincy Medical Group Quincy, IL Allergy and Immunology Section Upon completion of this activity, the participant

More information

PM-03 PED ALLERGY/ANAPHYLAXIS. Protocol SECTION: PM-03 PROTOCOL TITLE: PED ALLERGY/ANAPHYLAXIS REVISED: 01MAY2018

PM-03 PED ALLERGY/ANAPHYLAXIS. Protocol SECTION: PM-03 PROTOCOL TITLE: PED ALLERGY/ANAPHYLAXIS REVISED: 01MAY2018 SECTION: PROTOCOL TITLE: REVISED: 01MAY2018 BLS SPECIFIC CARE: See General Pediatric Care Protocol PM-1 - Determine patient s color category on length based resuscitation tape (Broselow Tape) Epi Pen Protocol

More information

Student Health Center

Student Health Center Referring Allergist Agreement Your patient is requesting that the University of Mary Washington Student Health Center (UMWSHC) administer allergy extracts provided by your office. Consistent with our policies

More information

Setting The setting was the community. The economic study was carried out in New Jersey, USA.

Setting The setting was the community. The economic study was carried out in New Jersey, USA. Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy Luskin A, Bukstein D, Kocevar V S, Yin D D Record Status This

More information

Case Study. Allergic Rhinitis 5/18/2015

Case Study. Allergic Rhinitis 5/18/2015 John A. Fling, M.D. Professor Allergy/Immunology University of North Texas Health Science Center, Fort Worth, Texas Case Study 38 year old male with a history of nasal congestion, clear nasal discharge

More information

Angioedema. Disclosures. Question #1. Objectives. Question #3. Question #2 12/28/2015. Differentiate the various angioedema subtypes

Angioedema. Disclosures. Question #1. Objectives. Question #3. Question #2 12/28/2015. Differentiate the various angioedema subtypes None Disclosures Jason Knuffman, M.D. Allergy and Clinical Immunology Quincy Medical Group Unity Point Health System Quincy, IL Objectives Question #1 Differentiate the various angioedema subtypes Identify

More information

Allergy The diagnostic process Main examinations and interpretation

Allergy The diagnostic process Main examinations and interpretation Brochure for healthcare professionals Allergy The diagnostic process Main examinations and interpretation Physical examination and medical interview As symptoms are not always typical and specific to allergic

More information

EAACI Congress 2019 SCIENTIFIC PROGRAMME HIGHLIGHTS 1-5 JUNE Lisbon, Portugal

EAACI Congress 2019 SCIENTIFIC PROGRAMME HIGHLIGHTS 1-5 JUNE Lisbon, Portugal EAACI Congress 2019 SCIENTIFIC PROGRAMME HIGHLIGHTS 1-5 JUNE 2019 Lisbon, Portugal WWW.EAACI.ORG Mapping the new world of allergy" at EAACI Congress 2019 This year we will offer you an innovative scientific

More information

A Retrospective Cross- sectional Study Evaluating Beta- lactam Allergy Labeling in Hospitalized Patients

A Retrospective Cross- sectional Study Evaluating Beta- lactam Allergy Labeling in Hospitalized Patients Pharmacy Residency Research Project Manuscript A Retrospective Cross- sectional Study Evaluating Beta- lactam Allergy Labeling in Hospitalized Patients Bingjie (Amy) Wang Pharmacy Resident Trillium Health

More information

Anaphylaxis: The Atypical Varieties

Anaphylaxis: The Atypical Varieties Anaphylaxis: The Atypical Varieties John Johnson, D.O., PGY-4 Allergy/Immunology Fellow University Hospitals of Cleveland Case Western Reserve University School of Medicine Disclosures: None What is Anaphylaxis?

More information

CONCLUSIONS: For the primary end point in the total population, there were no significant differences between treatments. There were small, but statis

CONCLUSIONS: For the primary end point in the total population, there were no significant differences between treatments. There were small, but statis V. Clinical Sciences A. Allergic Diseases and Related Disorders 1. Upper airway disease a. Clinical skills and interpretive strategies for diagnosis of upper airway diseases: skin testing (epicutaneous

More information

2012/12/5. Principle of the management of urticaria. The efficacy of systemic steroid on urticaria depends of subtypes urticaria

2012/12/5. Principle of the management of urticaria. The efficacy of systemic steroid on urticaria depends of subtypes urticaria 6 December 2012: 13:3015:00 G.04 (HICC) The Hyderabad International Convention Centre (HICC) in Hyderabad, India WISC 2012; WAO International Scientific Conference Postgraduate Course 16: URTICARIA & ANGIOEDEMA

More information

Anaphylaxis. Emergencies for the general physician. Shuaib Nasser Consultant in Allergy and Asthma Cambridge University Hospitals NHS Foundation Trust

Anaphylaxis. Emergencies for the general physician. Shuaib Nasser Consultant in Allergy and Asthma Cambridge University Hospitals NHS Foundation Trust Anaphylaxis Emergencies for the general physician Shuaib Nasser Consultant in Allergy and Asthma Cambridge University Hospitals NHS Foundation Trust Definition- Anaphylaxis A potentially life-threatening

More information

Associate Professor Rohan Ameratunga Immunologist & Allergist, Auckland

Associate Professor Rohan Ameratunga Immunologist & Allergist, Auckland Associate Professor Rohan Ameratunga Immunologist & Allergist, Auckland Update on desensitisation Associate Professor Rohan Ameratunga GLORIA Module 4: Allergen Specific Immunotherapy A New Zealand perspective

More information

Treatment Options for Complicated/Severe Asthma. Henry J. Kanarek, MD Kanarek Allergy Asthma Immunology

Treatment Options for Complicated/Severe Asthma. Henry J. Kanarek, MD Kanarek Allergy Asthma Immunology Treatment Options for Complicated/Severe Asthma Henry J. Kanarek, MD Kanarek Allergy Asthma Immunology www.kallergy.com 913-451-8555 Asthma Epidemiology World Health Organization, Asthma is one of the

More information

Sign up to receive ATOTW weekly -

Sign up to receive ATOTW weekly - ANAPHYLAXIS ANAESTHESIA TUTORIAL OF THE WEEK 38 1 th DECEMBER 2006 Dr. Sara Rees Cardiff, UK Case History You are anaesthetising a fit and well 40 year old woman for total abdominal hysterectomy for menorrhagia.

More information